Home > News

News

Nampak Plastics Europe Ltd v Alpla UK Ltd [2014] EWHC 2196 (Pat)3 July 2014Adrian Speck QC  and Henry Ward  recently appeared for Alpla in a summary judgment application concerning the shape of blow moulded plastic milk containers. Nampak had sued Alpla in respect of Alpla’s “ECO” design of plastic milk container, alleging that it infringed a patent owned by Nampak because of a certain feature of the geometry […]
PRCA v. Newspaper Licensing Agency Ltd Case C-360/135 June 2014Andrew Lykiardopoulos QC recently acted for the PRCA in the Supreme Court and reference to the Court of Justice. The case raised the important question of whether copies made on a user’s computer (on screen or in the internet cache) when browsing websites could constitute an infringement of copyright. The Court held that they cannot. […]
Shanks v Unilever [2014] EWHC 1647 (Pat)23 May 2014In Shanks v Unilever [2014] EWHC 1647 (Pat) , Arnold J has dismissed Prof Shanks’ appeal against the IPO’s rejection of his long-running multi-million pound claim for inventor’s compensation against his former employer, Unilever, in respect of patents which he claimed to be of ‘outstanding benefit’ to Unilever. The patents were in for the so-called electrochemical capillary […]
Generics (UK) Ltd (t/a Mylan) v Richter Gedeon Vegyeszeti Gyar RT [2014] EWHC 1666 (Pat)22 May 2014Lindsay Lane  recently appeared as part of Richter Gedeon Vegyeszeti Gyar RT’s legal team defending an invalidity and revocation claim brought by Generics UK Limited. The patent concerned a dosage regimen for use of levonorgestrel as a method of emergency contraception. The claim was brought on the grounds of obviousness and insufficiency. Sales J found […]
Actavis UK Limited and others v Eli Lilly & Company [2014] EWHC 1511 (Pat)15 May 2014Richard Meade QC and Isabel Jamal, together with Thomas Raphael, represented Actavis in its landmark win against Eli Lilly. Judgment was handed down on 15 May 2014 in the long-running patent dispute between Actavis and Eli Lilly regarding Lilly’s patent relating to the use of the anti-cancer drug pemetrexed disodium with vitamin B12 and (optionally) […]